{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:52:44Z","timestamp":1773867164083,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1136\/ijgc-00009577-200707000-00019","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T05:06:42Z","timestamp":1729487202000},"page":"879-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix"],"prefix":"10.1016","volume":"17","author":[{"given":"A.","family":"SHARMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"RAJAPPA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"SAXENA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"SHARMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0005","series-title":"A consolidated report of the population based cancer registries (1990\u20131999)","first-page":"60","author":"Programme","year":"2001"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0010","first-page":"1","article-title":"Epidemiology of cervical cancer","volume":"21","author":"Herrero","year":"1996","journal-title":"Monograph Natl Cancer Inst"},{"issue":"55","key":"10.1136\/ijgc-00009577-200707000-00019_bb0015","first-page":"891","article-title":"Implications for prevention and projections of future burden","volume":"1993","author":"Pisani M, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in","year":"1985","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-2478(83)90101-3","article-title":"Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells","volume":"6","author":"Rey","year":"1983","journal-title":"Immunol Lett"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0025","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/1097-0142(19851001)56:7<1553::AID-CNCR2820560715>3.0.CO;2-D","article-title":"Monocyte and lymphocyte interaction in patients with advanced cancer","volume":"56","author":"Santos","year":"1985","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(91)90188-L","article-title":"Evaluation of a test system for measuring cytokine production in human whole blood cell cultures","volume":"139","author":"Elsasser-Beile","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/CMR.9.4.532","article-title":"Type 1 and type 2 cytokine dys- regulation in human infectious, neoplastic and inflammatory diseases","volume":"9","author":"Lucey","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0167-5699(94)90220-8","article-title":"The TH1\/TH2 model of HIV infection: new insights","volume":"15","author":"Clerici","year":"1994","journal-title":"Immunol Today"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0167-5699(91)90120-I","article-title":"Human TH1 and TH2 subsets: doubt no more","volume":"12","author":"Romagnani","year":"1991","journal-title":"Immunol Today"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0050","first-page":"96","article-title":"Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer","volume":"2","author":"Tahara","year":"1995","journal-title":"Gene Ther"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00062752-199704010-00010","article-title":"Function and clinical use of interleukin-12","volume":"4","author":"Trincheri","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0060","series-title":"Immunobiology: the immune system in health and disease","author":"Janeway","year":"1997"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0065","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/1523-1747.ep12340161","article-title":"Interleukin-12 inhibits angiogenesis induced by human tumor cell lines in vivo","volume":"106","author":"Majewski","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.immunol.14.1.369","article-title":"Antigen processing and presentation by the class II major histocompatibility complex","volume":"14","author":"York","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0075","first-page":"456","article-title":"Gamma-interferon inhibits human papilloma virus type 16 gene transcription in human papilloma virus-immortalized human cervical cells","volume":"52","author":"Woodworth","year":"1992","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0167-5699(87)90171-X","article-title":"Two types of mouse T helper cell clone implication for immune regulation","volume":"8","author":"Mosmann","year":"1987","journal-title":"Immunol Today"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4049\/jimmunol.154.3.1280","article-title":"IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells","volume":"154","author":"Beissert","year":"1995","journal-title":"J Immunol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0095","first-page":"319","article-title":"Staging announcement: FIGO staging of gynecologic cancers (cervical and vulva)","volume":"5","author":"Keyes","year":"1995","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/jcm.35.3.791-795.1997","article-title":"A general primer GP51\/61 mediated PCR enzyme immunoassay method for rapid detection of 14 high risk and 6 low risk human papilloma virus genotypes in cervical scrapings","volume":"35","author":"Jacobs","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0105","first-page":"328","article-title":"Human papilloma virus infection of the cervix: relative risk associations of 15 common anogenital types","volume":"79","author":"Lorincs","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0110","first-page":"33","article-title":"Increased levels of Interleukin-4, 5 and 10 and decreased levels of interferon-gamma in lymphatic filariasis","volume":"16","author":"Sharma","year":"2005","journal-title":"Biomed Res"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0115","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jcp.2004.025072","article-title":"A shift to peripheral Th2- type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions","volume":"58","author":"Bais","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CDLI.8.2.209-220.2001","article-title":"Cell-mediated response to human papilloma virus infection","volume":"8","author":"Scott","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0125","first-page":"13153","article-title":"Interferon-c and tumor necrosis fac- tor-a synergism in ME180 cervical cancer cell apoptosis and necrosis","volume":"276","author":"Suk","year":"2001","journal-title":"J Biolumin Chemilumin"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/gyno.2001.6378","article-title":"Cytokine profile of cervical cancer cells","volume":"83","author":"Hazelbag","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0135","first-page":"852","article-title":"Circulating immune profile in patients with pre-cancer and cancer of the cervix: a cross sectional study among Indian women","volume":"80","author":"Gupta","year":"1993","journal-title":"Bull Cancer"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0140","first-page":"3967","article-title":"Interleukin-2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology","volume":"56","author":"Tsukui","year":"1996","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","article-title":"Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection","volume":"89","author":"Clerici","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0150","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"Natural killer cell stimulatory factor (IL-12) induces Th1-specific immune responses and inhibits the development of IL-4 producing T-helper cells","volume":"177","author":"Manetti","year":"1993","journal-title":"J Exp Med"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0155","first-page":"18","article-title":"Production of IL-10 by human bronchogenic carcinoma","volume":"145","author":"Smith","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ijc.2910630311","article-title":"Lack of IL-2 expression and selective expression of IL-10 mRNA in human renal cell carcinoma","volume":"63","author":"Nakagomi","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2249.1998.00437.x","article-title":"Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix","volume":"111","author":"Jacobs","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0170","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-04-0831","article-title":"Human papillomavirus type 16-positive cervical cancer is associated with impaired CD41 T-cell immunity against early antigens E2 and E6","volume":"64","author":"de Jong","year":"2004","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2249.1998.00639.x","article-title":"Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression","volume":"113","author":"Giannini","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0180","first-page":"285","article-title":"Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer","volume":"7","author":"Niwa","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/gyno.2001.6361","article-title":"Serum cytokine concentrations in patients with cervical cancer: interleukin-4, interferon-c, and monocyte chemoattractant protein-1","volume":"83","author":"Lebrecht","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0190","first-page":"3835","article-title":"Cytokines in gynecological cancer","volume":"17","author":"Sarandakou","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-00009577-200707000-00019_bb0195","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24029918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24029918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200707000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:23:06Z","timestamp":1753222986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24029918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":39,"aliases":["10.1111\/j.1525-1438.2007.00883.x"],"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1048891X24029918"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200707000-00019","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200707000-00019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IGCS and ESGO","name":"copyright","label":"Copyright"}]}}